Our data indicated a decrease of risk associated with interferon, even if it did not reach statistical significance.
← all excerpts
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
1
—
—
Our data indicated a decrease of risk associated with interferon, even if it did not reach statistical significance.